From Crisis to Control: A Comprehensive Update on Myasthenia Gravis Therapeutics and Care Strategies

From Crisis to Control: A Comprehensive Update on Myasthenia Gravis Therapeutics and Care Strategies

Objectives:

• Describe the fundamental facts about myasthenia gravis including pathophysiology, clinical presentation, and diagnostic findings
• Outline a comprehensive approach to the emergent management of Myasthenic Crisis
• Compare and contrast the role and application of corticosteroids versus non-steroidal immunosuppressive therapies in Myasthenia Gravis.
• Explain the current role and mechanisms of various immunomodulatory agents in the long-term management of Myasthenia Gravis.
• Identify common medications known to exacerbate Myasthenia Gravis symptoms

Record is available now!

Speaker: Dr. Raed Al-Othman, Neurology and Neuromuscular Medicine Consultant

Brief:

Bachelor of Medicine & Bachelor of Surgery (MBBS)- King Faisal University

Neurology – Ministry of National Guard Health Affairs – Saudi Commission for Health Specialties

Neuromuscular and Peripheral Nerve Disorders – University of Toronto, Canada